Daiwa Securities Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Hold |
429
| – | – | ﹤0.01% | 1131 |
|
|
2025
Q1 | $9K | Sell |
429
-18
| -4% | -$378 | ﹤0.01% | 1102 |
|
|
2024
Q4 | $14K | Hold |
447
| – | – | ﹤0.01% | 1099 |
|
|
2024
Q3 | $13K | Hold |
447
| – | – | ﹤0.01% | 1116 |
|
|
2024
Q2 | $17K | Hold |
447
| – | – | ﹤0.01% | 1130 |
|
|
2024
Q1 | $26K | Sell |
447
-38
| -8% | -$2.21K | ﹤0.01% | 1120 |
|
|
2023
Q4 | $29K | Buy |
485
+66
| +16% | +$3.95K | ﹤0.01% | 1099 |
|
|
2023
Q3 | $16K | Hold |
419
| – | – | ﹤0.01% | 1102 |
|
|
2023
Q2 | $38K | Sell |
419
-26
| -6% | -$2.36K | ﹤0.01% | 1076 |
|
|
2023
Q1 | $29K | Hold |
445
| – | – | ﹤0.01% | 1055 |
|
|
2022
Q4 | $23K | Buy |
445
+48
| +12% | +$2.48K | ﹤0.01% | 1072 |
|
|
2022
Q3 | $27K | Hold |
397
| – | – | ﹤0.01% | 1082 |
|
|
2022
Q2 | $18K | Buy |
397
+99
| +33% | +$4.49K | ﹤0.01% | 1110 |
|
|
2022
Q1 | $15K | Hold |
298
| – | – | ﹤0.01% | 1117 |
|
|
2021
Q4 | $14K | Hold |
298
| – | – | ﹤0.01% | 1127 |
|
|
2021
Q3 | $10K | Buy |
298
+139
| +87% | +$4.66K | ﹤0.01% | 1133 |
|
|
2021
Q2 | $10K | Hold |
159
| – | – | ﹤0.01% | 1040 |
|
|
2021
Q1 | $7K | Buy |
159
+17
| +12% | +$748 | ﹤0.01% | 1056 |
|
|
2020
Q4 | $8K | Sell |
142
-277
| -66% | -$15.6K | ﹤0.01% | 1023 |
|
|
2020
Q3 | $13K | Hold |
419
| – | – | ﹤0.01% | 1018 |
|
|
2020
Q2 | $11K | Hold |
419
| – | – | ﹤0.01% | 1048 |
|
|
2020
Q1 | $11K | Buy |
419
+58
| +16% | +$1.52K | ﹤0.01% | 1043 |
|
|
2019
Q4 | $11K | Sell |
361
-37
| -9% | -$1.13K | ﹤0.01% | 1041 |
|
|
2019
Q3 | $10K | Hold |
398
| – | – | ﹤0.01% | 1019 |
|
|
2019
Q2 | $10K | Buy |
398
+40
| +11% | +$1.01K | ﹤0.01% | 1039 |
|
|
2019
Q1 | $7K | Sell |
358
-142
| -28% | -$2.78K | ﹤0.01% | 1039 |
|
|
2018
Q4 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 1009 |
|